To confirm our hypothesis that acquired CFTR dysfunction can be detected beyond the airway and test whether the defect alters function of the glandular compartment, we used this assay in patients without CFTR mutations to quantify glandular CFTR activity while also assessing the phenotypic expression of COPD. The gene discussed is CFTR; the disease is chronic obstructive pulmonary disease.